| Literature DB >> 26005023 |
Craig A Avery1, Richard J Pease2, Kerrie Smith2, May Boothby2, Helen M Buckley2, Peter J Grant2, Colin W G Fishwick3.
Abstract
A novel class of potent FXIII-A inhibitors containing a (±) cis-bisamido epoxide pharmacophore is described. The compounds display highly potent inhibition of FXIII-A (IC50 = 5-500 nM) in an in vitro assay. In contrast to other types of previously described covalent transglutaminase inhibitors, the bis-amido epoxides exhibited no measurable reactivity with glutathione, therefore possibly rendering this class of compounds suitable for future in vivo investigations. Additionally, the compounds show selective inhibition for FXIII-A against the cysteine protease, cathepsin S although they proved to have similar potency with a closely related transglutaminase, TGII, to that observed for FXIII-A.Entities:
Keywords: Bis-amido epoxides molecular modelling; FXIII-A; Thrombosis
Mesh:
Substances:
Year: 2015 PMID: 26005023 DOI: 10.1016/j.ejmech.2015.05.019
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514